HER2 testing in gastric cancer: results of a German expert meeting-Reference-Cited by-同舟云学术

HER2 testing in gastric cancer: results of a German expert meeting

Published:2017-03-11 Issue:5 Volume:143 Page:835-841
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Lordick Florian^ORCID,Al-Batran Salah-Eddin,Dietel Manfred,Gaiser Timo,Hofheinz Ralf-Dieter,Kirchner Thomas,Kreipe Hans H.,Lorenzen Sylvie,Möhler Markus,Quaas Alexander,Röcken Christoph,Rüschoff Josef,Tannapfel Andrea,Thuss-Patience Peter,Baretton Gustavo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-017-2374-x.pdf

Reference24 articles.

1. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK, ToGA Trial Investigators (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697

2. Barros-Silva JD, Leitão D, Afonso L, Vieira J, Dinis-Ribeiro M, Fragoso M, Bento MJ, Santos L, Ferreira P, Rêgo S, Brandão C, Carneiro F, Lopes C, Schmitt F, Teixeira MR (2009) Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer 100:487–493

3. Brien TP, Depowski PL, Sheehan CE, Ross JS, McKenna BJ (1998) Prognostic factors in gastric cancer. Mod Pathol 11:870–877

4. Choritz H, Büsche G, Kreipe H, Study Group HER2 Monitor (2011) Quality assessment of HER2 testing by monitoring of positivity rates. Virchows Arch 459:283–289

5. Chung HC, Bang YJ, Xu JM, Lordick F, Sawaki A, Lipatov O, Lehle M, Pickl M, Ruschoff J, Cutsem EV (2009) Human epidermal growth factor receptor 2 (HER2) in gastric cancer (GC): results of the ToGA trial screening programme and recommendations for HER2 testing. EJC Suppl 7:364

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemtherapie des Magenkarzinoms im Stadium IV – aktuelle Entwicklungen;Die Onkologie;2024-07-02

2. Molekularpathologie gastrointestinaler Tumoren;Die Gastroenterologie;2024-03-28

3. Impact of HER2-Low Status in Metastatic Gastric Cancer: A Real-World Retrospective Cohort Study;Oncology;2024-02-14

4. Progress in research of tumor biomarkers and molecular imaging probes for gastric cancer;World Chinese Journal of Digestology;2024-01-28

5. German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer;Gastric Cancer;2023-10-17